Kubota, T., Namba, N., Kurotobi, S., Kogaki, S., Hirai, H., Kitaoka, T., . . . Ozono, K. (2006). Beneficial Effect of Oral Bisphosphonate Treatment on Bone Loss Induced by Chronic Administration of Furosemide without Alteration of Its Administration and Urinary Calcium Loss. The Japanese Society for Pediatric Endocrinology.
Citação norma ChicagoKubota, Takuo, Noriyuki Namba, Shunji Kurotobi, Shigetoyo Kogaki, Haruhiko Hirai, Taichi Kitaoka, Shigeo Nakajima, and Keiichi Ozono. Beneficial Effect of Oral Bisphosphonate Treatment On Bone Loss Induced By Chronic Administration of Furosemide Without Alteration of Its Administration and Urinary Calcium Loss. The Japanese Society for Pediatric Endocrinology, 2006.
Citação norma MLAKubota, Takuo, et al. Beneficial Effect of Oral Bisphosphonate Treatment On Bone Loss Induced By Chronic Administration of Furosemide Without Alteration of Its Administration and Urinary Calcium Loss. The Japanese Society for Pediatric Endocrinology, 2006.